Use of recombinant factor VIIa (Novoseven) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation.
Velik-Salchner
Corinna
C
*Department of Anaesthesia and Intensive Care Medicine †Department of Pathology ‡Department of Pediatrics; Innsbruck Medical University; Innsbruck, Austria; corinna.velik@uibk.ac.at.
Sergi
Consolato
C
Fries
Dietmar
D
Moser
Patrizia
P
Streif
Werner
W
Kolbitsch
Christian
C
D001916:Brachial Artery; D015199:Extracorporeal Membrane Oxygenation; D015942:Factor VIIa / Q000009:adverse effects* / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006487:Hemostasis; D006801:Humans; D007231:Infant, Newborn; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013348:Subclavian Artery; D013927:Thrombosis / Q000139:chemically induced*
D011994:Recombinant Proteins; D015942:Factor VIIa